Costa Rica vs Senegal: HIV-positive TB patients on ART (antiretroviral therapy)
Costa Rica
72.0%
in 2024
Senegal
74.0%
in 2024
Costa Rica rank
123rd
Senegal rank
121st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Costa Rica
- Senegal
How they compare
Senegal currently reports 74.0% against 72.0% in Costa Rica, a difference of 2.0%.
The two have swapped places 3 times across 11 shared years of data; in 2012 it was Costa Rica ahead.
Costa Rica ranks 123rd and Senegal ranks 121st of 144 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 96.8% | 85.5% | 11.2% | Costa Rica |
| 2020s | 90.7% | 87.0% | 3.7% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Costa Rica or Senegal?
- Senegal, at 74.0% against 72.0% in Costa Rica as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Costa Rica and Senegal?
- 2.0%, with Senegal ahead.
- How many years of comparable data are there for Costa Rica and Senegal?
- 11 years are reported by both, from 2012 to 2024.
- How do Costa Rica and Senegal rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Costa Rica ranks 123rd and Senegal ranks 121st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.